About Us
Our Vision
Research staff spending more time on what matters so new treatments can get to patients faster
Our Mission
Be the next-generation solution for study data interconnectivity
Our Values
Health
Our company exists to help researchers collect study data fast, enabling vital treatments to reach patients sooner.
Because health matters to everyone – our customers, our family and our staff – we care passionately about this role and our responsibilities.
Trust
We believe that trust is earned: our team is focused on ensuring that all we do is delivered to stringent industry protocols and the highest service standards.
Quality and data security are in our DNA and are what sets our people apart.
Collaboration
Our success is rooted in powerful collaborations, forged with world-renowned research sites and global pharma.
Internally and externally, our culture of inclusion and respect means we are always guided by insights, expertise and clearly defined needs.
Our Story
2013 A meeting of minds
IgniteData founders Dan Hydes and Richard Yeatman meet and work together as business and commercial consultants at a leading NHS Foundation Trust. Their work in the NHS leads them to see firsthand the data system silos and inefficiencies involved in running clinical trials at large research-active hospitals.
2014 Vision: IgniteData
IgniteData is formed with the aim of helping to deliver efficiencies in modern clinical trials through the automated transfer of data between systems. The technology isn’t quite ready to create the scalable, system-agnostic tool that Dan and Richard envisage, so they park the idea and continue building IgniteData’s expertise in supporting clinical trial delivery.
2014- 2019 Building
IgniteData successfully delivers numerous clinical trial data projects, including in patient recruitment, feasibility and real-world studies. All the while the team are continuing to build and expand their expertise in clinical trials and reaffirming their vision for a tool that will help change things for the better.
2019 Hello Archer
Advances in the technologies used in EHR systems finally mean the time is right to start building the tool Dan and Richard envisage. A grant from Innovate UK helps build a prototype, and Archer – the Virtual Research Assistant – is born. It is designed to be the world’s first truly agnostic tool to safely automate the transfer of clinical data from EHR to EDC.
2020 Selected
The emergence of the Covid-19 pandemic makes Archer – which allows for less in-person visits to clinical trial sites – even more relevant. The team win three further grants, in all being awarded over £1 million in government funding to develop Archer.
Archer is shortlisted in a vendor selection process run by the EHR2EDC Consortium (led by AstraZeneca, Janssen and Sanofi) and, ultimately, comes out at the top. This kick-starts a partnership with AstraZeneca to pilot the use of Archer in a hospital setting.
February 2022 Turbo-drive
IgniteData announces a multimillion dollar investment and partnership with global professional services firm ZS, to turbocharge the transformation of patient data automation in clinical trials with Archer.
Through ZS’s worldwide life sciences presence, the partnership will open up the benefits of Archer to health systems and sponsors on a global scale.
September 2022 Go-live
In a pivotal moment for the modernisation of clinical trials, Archer is put into action in an oncology trial. In collaboration with AstraZeneca and University College London Hospitals (UCLH), the pilot automates the transfer of data between UCLH’s Epic EHR and AstraZeneca’s Medidata Rave EDC.
June 2023 Joining the MSK Innovation Hub
IgniteData announces a new collaboration with Memorial Sloan Kettering Cancer Center (MSK) – providing a data transfer integration between the EHR at MSK and the electronic systems of two major clinical trial sponsors, with the expectation of expanding this project to include additional sponsors and trials.
Our Founders
